<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The τ pathology found in <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (AD) is crucial in <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Midlife development of <z:hpo ids='HP_0001513'>obesity</z:hpo>, a major risk factor of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, increases the risk of <z:hpo ids='HP_0000726'>dementia</z:hpo> and AD later in life </plain></SENT>
<SENT sid="2" pm="."><plain>The impact of <z:hpo ids='HP_0001513'>obesity</z:hpo> on AD risk has been suggested to be related to central <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, secondary to peripheral <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The effects of diet-induced <z:hpo ids='HP_0001513'>obesity</z:hpo> (DIO) on τ pathology remain unknown </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, we evaluated effects of a high-fat diet, given at an early pathological stage, in the THY-Tau22 transgenic mouse model of progressive AD-like τ pathology </plain></SENT>
<SENT sid="5" pm="."><plain>We found that early and progressive <z:hpo ids='HP_0001513'>obesity</z:hpo> potentiated spatial learning deficits as well as hippocampal τ pathology at a later stage </plain></SENT>
<SENT sid="6" pm="."><plain>Surprisingly, THY-Tau22 mice did not exhibit peripheral <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Further, pathological worsening occurred while hippocampal insulin signaling was upregulated </plain></SENT>
<SENT sid="8" pm="."><plain>Together, our data demonstrate that DIO worsens τ phosphorylation and learning abilities in τ transgenic mice independently from peripheral/central <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
</text></document>